| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sotirios G Doukas, Andrea P Santos, Waleed Mir, Sarosh Daud, Tracy H Zivin-Tutel. A Rare Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Transverse Myelitis in a 40-Year-Old Patient With COVID-19. Cureus. vol 14. issue 4. 2022-05-09. PMID:35530898. |
serum aquaporin-4 immunoglobulin g was negative, and myelin oligodendrocyte glycoprotein (mog) antibodies were positive. |
2022-05-09 |
2023-08-13 |
human |
| Hiroyuki Hokama, Yuki Sakamoto, Toshiyuki Hayashi, Seira Hatake, Mizuho Takahashi, Hiroto Kodera, Akihito Kutsuna, Chikako Nito, Shunya Nakane, Hiroshi Nagayama, Toshiyuki Takahashi, Kazumi Kimur. A Case Report of FLAMES with Elevated Myelin Basic Protein Followed by Myelitis. Internal medicine (Tokyo, Japan). 2022-05-08. PMID:35527028. |
the pathophysiology of unilateral cortical fluid-attenuated inversion recovery (flair)-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein (mog)-associated encephalitis with seizures (flames) is unclear. |
2022-05-08 |
2023-08-13 |
Not clear |
| Sarah A Cooper, Sara Geraldine Leddy, Nicholas Tom Skipper, Victoria J M Barrett, Gordon T Plan. Optic neuritis with potential for poor outcome. Practical neurology. 2022-05-02. PMID:35501141. |
since then, non-ms cases of on have been identified with antibodies to aquaporin-4 (aqp4) or myelin oligodendrocyte glycoprotein (mog). |
2022-05-02 |
2023-08-13 |
Not clear |
| Michela Ada Noris Ferilli, Claudia Papi, Mario Sabatelli, Cesare Colosimo, Raffaele Iori. MOG autoimmunity mimicking CLIPPERS syndrome: Case report and literature review. Journal of neuroimmunology. vol 367. 2022-05-01. PMID:35490445. |
to date, several cases of neurological disorders with a clippers-like phenotype have been described, including patients with immunoglobulin g (igg) antibodies binding to myelin oligodendrocyte glycoprotein (mog). |
2022-05-01 |
2023-08-13 |
Not clear |
| Xin Yue Zhang, Dong Mei An, Ling Li. MOG antibody disease with ovarian teratoma: A case report and review of the literature. Journal of neuroimmunology. vol 367. 2022-04-29. PMID:35487122. |
myelin oligodendrocyte glycoprotein (mog) antibody disease is a rare inflammatory disease of the central nervous system. |
2022-04-29 |
2023-08-13 |
Not clear |
| Samir Alkabie, Yiu-Chia Chang, Adrian Budhram, Juan Manuel Racost. Pearls & Oy-sters: Gait Instability, Jaw Dystonia, and Horizontal Diplopia in a Woman With Anti-Ri Antibodies and Breast Cancer. Neurology. 2022-04-29. PMID:35487696. |
testing for aquaporin 4 (aqp4)-igg and myelin oligodendrocyte glycoprotein (mog)-igg by cell-based assay were negative. |
2022-04-29 |
2023-08-13 |
mouse |
| Abdulhafeez M Khair, Rahul Nikam, Sumair Husain, Melanie Ortiz, Gurcharanjeet Kau. Para and Post-COVID-19 CNS Acute Demyelinating Disorders in Children: A Case Series on Expanding the Spectrum of Clinical and Radiological Characteristics. Cureus. vol 14. issue 3. 2022-04-27. PMID:35475081. |
a 16-year-old female with anti-myelin oligodendrocyte glycoprotein (mog) disorder, an eight-year-old male with acute disseminated encephalomyelitis (adem), a 13-year-old female with neuromyelitis optica spectrum disorder (nmosd), and two 14 and 13-year-old females with new-onset multiple sclerosis (ms) are reported, all of whom presented acutely following covid-19 infection. we propose that para and post-infectious cns demyelinating disorders can potentially follow acute covid-19 infection in children. |
2022-04-27 |
2023-08-13 |
Not clear |
| Toshihiro Ide, Takeru Kawanami, Makoto Eriguchi, Hideo Har. SARS-CoV-2-related Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review. Internal medicine (Tokyo, Japan). vol 61. issue 8. 2022-04-19. PMID:35135920. |
we herein report a case of myelin oligodendrocyte glycoprotein (mog) antibody-associated disease after severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection. |
2022-04-19 |
2023-08-16 |
Not clear |
| Aigli G Vakrakou, Maria-Evgenia Brinia, Ioanna Svolaki, Theodore Argyrakos, Leonidas Stefanis, Constantinos Kilidirea. Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases. Frontiers in neurology. vol 13. 2022-04-14. PMID:35418930. |
tdl can emerge not only as part of the spectrum of classic multiple sclerosis (ms) but also can represent an idiopathic monophasic disease, a relapsing disease with recurrent tdl, or could be part of the myelin oligodendrocyte glycoprotein (mog)- and aquaporin-4 (aqp4)-associated disease. |
2022-04-14 |
2023-08-13 |
Not clear |
| Jae-Won Hyun, Yeseul Kim, Ki Hoon Kim, Su-Hyun Kim, Mads Nikolaj Olesen, Nasrin Asgari, Sasitorn Siritho, Friedemann Paul, Ho Jin Ki. CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage. Journal of neuroinflammation. vol 19. issue 1. 2022-04-13. PMID:35413922. |
despite rigorous confirmation with reliable assays, some individuals showing the neuromyelitis optica spectrum disorder (nmosd) phenotype remain negative for both aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibodies. |
2022-04-13 |
2023-08-13 |
Not clear |
| Ellen Yang, Adnan Husein, Jose Martinez-Perez, Terrence L. Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies. Case reports in neurological medicine. vol 2022. 2022-04-11. PMID:35399911. |
myelin oligodendrocyte glycoprotein (mog) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. |
2022-04-11 |
2023-08-13 |
Not clear |
| Alessandro Dinoto, Elia Sechi, Eoin P Flanagan, Sergio Ferrari, Paolo Solla, Sara Mariotto, John J Che. Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease. Frontiers in neurology. vol 13. 2022-04-11. PMID:35401423. |
more recently, antibodies against myelin oligodendrocyte glycoprotein (mog-igg), have been found to be a biomarker of a different entity, termed mog antibody-associated disease (mogad), which has overlapping, but different pathogenesis, clinical features, treatment response, and prognosis when compared to aqp4-igg-positive nmosd. |
2022-04-11 |
2023-08-13 |
Not clear |
| Andrew J Martin, James Strathdee, Nigel Wolf. Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology. BMJ neurology open. vol 4. issue 1. 2022-04-11. PMID:35402916. |
anti-myelin oligodendrocyte glycoprotein (mog)-associated disorders are heterogeneous and associated predominantly with central nervous system demyelination. |
2022-04-11 |
2023-08-13 |
Not clear |
| Junxia Fu, Yongping Wang, Hongen Li, Huanfen Zhou, Honglu Song, Mingming Sun, Quangang Xu, Shaoying Tan, Shihui We. Efficacy of Plasma Exchange Treatment for Demyelinating Optic Neuritis Associated with Various Serum Antibodies: A Prospective Cohort Study. Neurology and therapy. 2022-04-09. PMID:35397098. |
to evaluate the value of plasma exchange (pe) for patients with three subtypes of demyelinating optic neuritis (on): aquaporin-4 (aqp4) antibody-positive on (aqp4-on), myelin oligodendrocyte glycoprotein (mog) antibody-positive on (mog-on), and aqp4 and mog double-antibody-seronegative on (d-on). |
2022-04-09 |
2023-08-13 |
Not clear |
| Kentaro Tokumoto, Takuji Nishida, Norihiko Kawaguchi, Kimihiko Kaneko, Toshiyuki Takahashi, Yukitoshi Takahash. Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: A case report and literature review. Seizure. vol 98. 2022-04-09. PMID:35397246. |
myelin oligodendrocyte glycoprotein (mog) antibodies (abs) are associated with various central nervous system demyelinating disorders. |
2022-04-09 |
2023-08-13 |
Not clear |
| Sonya Bells, Giulia Longoni, Tara Berenbaum, Cynthia B de Medeiros, Sridar Narayanan, Brenda L Banwell, Douglas L Arnold, Donald J Mabbott, E Ann Ye. Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders. NeuroImage. Clinical. vol 34. 2022-04-05. PMID:35381508. |
the impact of multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein (mog) - associated disorders (mogad) on brain structure in youth remains poorly understood. |
2022-04-05 |
2023-08-13 |
Not clear |
| Kyoko Maruta, Yasuyuki Nobuhara, Yuji Ijiri, Fumikazu Kojima, Hiroshi Takashim. [Right optic perineuritis and myelitis 6 years following left optic perineuritis in anti-myelin oligodendrocyte glycoprotein-associated disorder: a case report]. Rinsho shinkeigaku = Clinical neurology. 2022-03-31. PMID:35354728. |
we report a patient with myelin oligodendrocyte glycoprotein (mog) antibody positivity who manifested myelitis with right optic perineuritis (opn) 6 years following left opn. |
2022-03-31 |
2023-08-13 |
Not clear |
| Sabine Tacke, Rittika Chunder, Verena Schropp, Eduard Urich, Stefanie Kuerte. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis. International journal of molecular sciences. vol 23. issue 6. 2022-03-25. PMID:35328594. |
male hcd20xhigr3 mice and wild-type c57bl/6 (b6) mice were immunized with human myelin oligodendrocyte glycoprotein (mog) |
2022-03-25 |
2023-08-13 |
mouse |
| Tianxin Yao, Qianqian Zeng, Yuanyuan Xie, Fangfang Bi, Le Zhang, Bo Xiao, Jinxia Zho. Clinical analysis of adult MOG antibody-associated cortical encephalitis. Multiple sclerosis and related disorders. vol 60. 2022-03-23. PMID:35320766. |
to describe the clinical and neuroimaging features, treatment response and outcomes of adult myelin oligodendrocyte glycoprotein (mog) antibody-associated cortical encephalitis. |
2022-03-23 |
2023-08-13 |
Not clear |
| Yuki Matsumoto, Ayane Ohyama, Takafumi Kubota, Kensuke Ikeda, Kimihiko Kaneko, Yoshiki Takai, Hitoshi Warita, Toshiyuki Takahashi, Tatsuro Misu, Masashi Aok. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review. Frontiers in neurology. vol 13. 2022-03-18. PMID:35299613. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) is a newly identified autoimmune demyelinating disorder that is often associated with acute disseminated encephalomyelitis and usually occurs postinfection or postvaccination. |
2022-03-18 |
2023-08-13 |
Not clear |